Short Interest in Shionogi & Co., Ltd. (OTCMKTS:SGIOY) Grows By 65.4%

Shionogi & Co., Ltd. (OTCMKTS:SGIOY - Get Free Report) was the target of a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 229,900 shares, an increase of 65.4% from the December 31st total of 139,000 shares. Based on an average daily trading volume, of 495,500 shares, the short-interest ratio is presently 0.5 days.

Shionogi & Co., Ltd. Stock Down 0.3 %

Shares of SGIOY stock traded down $0.02 during mid-day trading on Wednesday, hitting $6.92. 131,310 shares of the stock traded hands, compared to its average volume of 211,603. The company's 50-day simple moving average is $7.09 and its 200-day simple moving average is $8.49. Shionogi & Co., Ltd. has a twelve month low of $6.22 and a twelve month high of $9.11.

Shionogi & Co., Ltd. (OTCMKTS:SGIOY - Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.16 earnings per share for the quarter. Shionogi & Co., Ltd. had a net margin of 35.53% and a return on equity of 11.95%. Equities analysts expect that Shionogi & Co., Ltd. will post 0.66 earnings per share for the current fiscal year.

Shionogi & Co., Ltd. Company Profile

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.